Superseded. Newer COA available for this product: view newer COA.

Dual Incretin Agonist 10mg — Verification Report

From TriVial BioWorks · Lot TR10-0522 · Tested May 2026

← Back to TriVial BioWorks

VialTalk

Verification report

Dual Incretin Agonist 10mg

TriVial BioWorks

Score

89.1

Grade

Good

Lot TR10-0522

Tested May 2026

Report ID

94ce71a2

Test

Method

Result

Status

PurityFull credit

HPLC

99.57%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentPartial

Gravimetric vs label claim · tested weight not disclosed

10 mg labeled · 11.68 mg tested

Partial

EndotoxinFull credit

USP <85> compendial

Screened

Full credit

Heavy metalsFull credit

ICP-MS

Screened

Full credit

Batch conformityPartial

Two-batch average

Assessed

Partial

SterilityNot submitted

Not tested

Not submitted

Additional screens, not scoredFentanyl screen

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →